WO1998003510B1 - - Google Patents

Info

Publication number: WO1998003510B1
Authority: WO; WIPO (PCT)
Prior art keywords: compound; stereoisomeric forms; ome; isomers; dimethyl
Prior art date: 1997-07-23

Application number

PCT/US1997/013072

Other languages

English (en)

Other versions

WO1998003510A1 (fr

Filing date

1997-07-23

Publication date

1998-04-02

1997-07-23 Priority to EA199900158A priority Critical patent/EA004403B1/ru

1997-07-23 Priority to PL97331523A priority patent/PL195762B1/pl

1997-07-23 Priority to IL12787197A priority patent/IL127871A0/xx

1997-07-23 Priority to AU38942/97A priority patent/AU747708B2/en

1997-07-23 Priority to HU0102187A priority patent/HU228962B1/hu

1997-07-23 Priority to SK97-99A priority patent/SK286461B6/sk

1997-07-23 Priority to NZ333777A priority patent/NZ333777A/en

1997-07-23 Priority to EP97936222A priority patent/EP0915880B1/fr

1997-07-23 Priority to KR1019997000568A priority patent/KR100548853B1/ko

1997-07-23 Priority to IL15016397A priority patent/IL150163A0/xx

1997-07-23 Priority to UA99010100A priority patent/UA73913C2/uk

1997-07-23 Priority to DE69738197T priority patent/DE69738197T2/de

1997-07-23 Priority to SI9720045A priority patent/SI9720045B/sl

1997-07-23 Priority to RO99-00078A priority patent/RO121272B1/ro

1997-07-23 Priority to JP50723398A priority patent/JP4704521B2/ja

1997-07-23 Priority to BR9710544A priority patent/BR9710544A/pt

1997-07-23 Application filed filed Critical

1997-07-23 Priority to CA002259583A priority patent/CA2259583C/fr

1997-07-23 Priority to HU0500549A priority patent/HU229024B1/hu

1997-07-23 Priority to EEP199900019A priority patent/EE04316B1/xx

1997-07-23 Priority to DK97936222T priority patent/DK0915880T3/da

1998-01-29 Publication of WO1998003510A1 publication Critical patent/WO1998003510A1/fr

1998-04-02 Publication of WO1998003510B1 publication Critical patent/WO1998003510B1/en

1998-12-30 Priority to IL127871A priority patent/IL127871A/en

1999-01-20 Priority to LVP-99-13A priority patent/LV12292B/en

1999-01-21 Priority to NO19990264A priority patent/NO315610B3/no

2002-03-12 Priority to AU23236/02A priority patent/AU773039C/en

2002-06-11 Priority to IL150163A priority patent/IL150163A/en

2004-10-12 Priority to IL164513A priority patent/IL164513A/en

Priority Applications (26)

Application Number	Priority Date	Filing Date	Title
JP50723398A JP4704521B2 (ja)	1996-07-24	1997-07-23	アゾロトリアジン類およびアゾロピリミジン類
IL12787197A IL127871A0 (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines
AU38942/97A AU747708B2 (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines
HU0102187A HU228962B1 (en)	1996-07-24	1997-07-23	Azolo triazines, pharmaceutical compositions containing them and use of the compounds
SK97-99A SK286461B6 (sk)	1996-07-24	1997-07-23	[1,5-a]-Pyrazolo-1,3,5-triazíny, ich použitie a farmaceutické kompozície na ich báze
NZ333777A NZ333777A (en)	1996-07-24	1997-07-23	(1,5-a) pyrazolo and triazole triazines and pyrimidines
EP97936222A EP0915880B1 (fr)	1996-07-24	1997-07-23	Azolo triazines et pyrimidines
KR1019997000568A KR100548853B1 (ko)	1996-07-24	1997-07-23	아졸로 트리아진 및 피리미딘
IL15016397A IL150163A0 (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines
UA99010100A UA73913C2 (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines
DE69738197T DE69738197T2 (de)	1996-07-24	1997-07-23	Azolotriazine und pyrimidine
SI9720045A SI9720045B (sl)	1996-07-24	1997-07-23	Azolo triazini in pirimidini
RO99-00078A RO121272B1 (ro)	1996-07-24	1997-07-23	Azolotriazine şi pirimidine
EA199900158A EA004403B1 (ru)	1996-07-24	1997-07-23	Производные пиразолотриазинов, фармацевтические композиции, содержащие их, способы лечения
EEP199900019A EE04316B1 (et)	1996-07-24	1997-07-23	Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks
BR9710544A BR9710544A (pt)	1996-07-24	1997-07-23	M-todo de tratamento composto e composi-Æo farmac-utica
CA002259583A CA2259583C (fr)	1996-07-24	1997-07-23	Azolo triazines et pyrimidines
HU0500549A HU229024B1 (en)	1996-07-24	1997-07-23	Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
PL97331523A PL195762B1 (pl)	1996-07-24	1997-07-23	Związki [1,5-a]pirazolo-1,3,5-triazynowe, środek farmaceutyczny i zastosowanie związków [1,5-a]pirazolo-1,3,5-triazynowych do wytwarzania leku
DK97936222T DK0915880T3 (da)	1996-07-24	1997-07-23	Azolotriaziner og pyrimidiner
IL127871A IL127871A (en)	1996-07-24	1998-12-30	PHARMACEUTICAL COMPOSITIONS CONTAINING CRF ANTAGONIST 3-ARYL-PYRAZOLO (AND 1,2,3-TRIAZOLO) [1,5-a]-1,3,5-TRIAZINE DERIVATIVES AND SOME NEW SUCH DERIVATIVES
LVP-99-13A LV12292B (en)	1996-07-24	1999-01-20	TRIANGLE AND PYRIMIDINES AZOL-DERIVATIVES
NO19990264A NO315610B3 (no)	1996-07-24	1999-01-21	Azolotriaziner og -pyrimidiner
AU23236/02A AU773039C (en)	1996-07-24	2002-03-12	Azolo triazines and pyrimidines
IL150163A IL150163A (en)	1996-07-24	2002-06-11	PHARMACEUTICAL COMPOSITIONS COMPRISING PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND SOME NOVEL SUCH COMPOUNDS
IL164513A IL164513A (en)	1996-07-24	2004-10-12	Pyrazolopyrimidines, pharmaceutical compositions containing them and their use in the preparation of medicaments

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US2329096P	1996-07-24	1996-07-24
US68604796A	1996-07-24	1996-07-24
US08/686,047		1996-07-24
US60/023,290		1996-07-24

Publications (2)

Publication Number	Publication Date
WO1998003510A1 WO1998003510A1 (fr)	1998-01-29
WO1998003510B1 true WO1998003510B1 (fr)	1998-04-02

Family

ID=26696934

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/US1997/013072 WO1998003510A1 (fr)	1996-07-24	1997-07-23	Azolo triazines et pyrimidines

Country Status (17)

Country	Link
EP (2)	EP0915880B1 (fr)
KR (1)	KR100548853B1 (fr)
AR (1)	AR007994A1 (fr)
AT (1)	ATE375344T1 (fr)
AU (1)	AU747708B2 (fr)
CZ (1)	CZ2005613A3 (fr)
DE (1)	DE69738197T2 (fr)
DK (1)	DK0915880T3 (fr)
EA (1)	EA006626B1 (fr)
ES (1)	ES2294800T3 (fr)
HK (1)	HK1052693A1 (fr)
HU (2)	HU228962B1 (fr)
LV (1)	LV12292B (fr)
PT (1)	PT915880E (fr)
RO (1)	RO121272B1 (fr)
TW (2)	TW542827B (fr)
WO (1)	WO1998003510A1 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7094782B1 (en)	1996-07-24	2006-08-22	Bristol-Myers Squibb Company	Azolo triazines and pyrimidines
JP2001511813A (ja)	1997-02-18	2001-08-14	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	Ｃｒｆレセプターアンタゴニストおよびそれらに関連する方法
ES2218991T3 (es) *	1998-01-28	2004-11-16	Bristol-Myers Squibb Pharma Company	Pirazolotriazinas como antagonistas de crf.
WO1999045007A1 (fr) *	1998-03-06	1999-09-10	Janssen Pharmaceutica N.V.	Pyrazolo[4,3-b]pyridines antagonistes du facteur de liberation de la corticotropine (crf)
US6509338B1 (en)	1998-06-22	2003-01-21	Bristol-Myers Squibb Company	Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
CN1217945C (zh)	1998-11-12	2005-09-07	纽罗克里恩生物科学有限公司	Crf受体拮抗剂以及与其有关的方法
NZ511267A (en)	1998-11-12	2002-12-20	Neurocrine Biosciences Inc	Tricyclic heterocyclic CRF receptor antagonists and their use in treatment
AU4203500A (en) *	1999-04-06	2000-10-23	Du Pont Pharmaceuticals Company	Pyrazolopyrimidines as crf antagonists
AU4331500A (en)	1999-04-06	2000-10-23	Du Pont Pharmaceuticals Company	Pyrazolotriazines as crf antagonists
US6432989B1 (en)	1999-08-27	2002-08-13	Pfizer Inc	Use of CRF antagonists to treat circadian rhythm disorders
CA2379585C (fr)	1999-09-30	2006-06-20	James W. Darrow	Pyrazolo[1,5,-a]-1,5-pyrimidines a substitution alkylene-diamine et pyrazolo[1,5-a]-1,3,5-triazines
DE60032249T2 (de) *	1999-09-30	2007-07-19	Neurogen Corp., Branford	Amino-substituierte Pyrazolo-[1,5-a]-1,5-Pyrimidine und Pyrazolo-[1,5-a]-1,3,5-Triazine
NZ517575A (en) *	1999-09-30	2004-04-30	Neurogen Corp	Certain alkylene diamine-substituted heterocycles
KR20030016222A (ko) *	2000-02-14	2003-02-26	니뽄 다바코 산교 가부시키가이샤	수술후 스트레스 예방ㆍ치료제
CA2419626A1 (fr) *	2000-07-14	2002-01-24	Rajagopal Bakthavatachalam	Imidazo¬1,2-a\|pyrazines destinees au traitement d'affections neurologiques
EP1305637A2 (fr) *	2000-08-02	2003-05-02	Malope Company Limited	Diagnostic et traitement de la dyspepsie non ulcereuse fondes sur l'anomalie de l'axe hypothalamo-hypophyso-surrenalien
KR100875595B1 (ko)	2001-03-13	2008-12-23	브리스톨-마이어스 스퀴브 파마 컴파니	코르티코트로핀 방출인자 수용체 리간드로서4-(2-부틸아미노)-2,7-디메틸-8-(2-메틸-6-메톡시피리드-3-일) 피라졸로-[1,5-에이]-1,3,5-트리아진, 그의 거울상이성질체 및 약학적으로 허용가능한 염
RU2003135424A (ru)	2001-05-14	2005-05-20	Бристол-Маерс Сквибб Фарма Компани (Us)	Замещенные пиразиноны, пиридины и пиримидины в качестве лигандов кортикотропин высвобождающего фактора
WO2003005969A2 (fr)	2001-07-12	2003-01-23	Bristol-Myers Squibb Pharma Company	Tetrahydropurinones et leurs derives en tant que ligands du recepteur du facteur de liberation de corticotropine
US7276526B2 (en)	2001-07-13	2007-10-02	Bristol-Myers Squibb Pharma Company	Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
US20030119831A1 (en)	2001-11-20	2003-06-26	Hartz Richard A.	3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands
ES2245772T3 (es)	2002-03-07	2006-01-16	Smithkline Beecham Corporation	Derivados de pirazolopirimidina y pirazolotriazina y composiciones farmaceuticas que los contienen.
DE60318697T2 (de)	2002-04-26	2009-01-08	Eli Lilly And Co., Indianapolis	Triazolderivate als tachykininrezeptor-antagonisten
FR2842809A1 (fr) *	2002-07-26	2004-01-30	Greenpharma Sas	NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
FR2850653A1 (fr) *	2003-02-04	2004-08-06	Univ Pasteur	Derives de pyrazolotriazine, procede de preparation et utilisations
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7112585B2 (en)	2003-04-18	2006-09-26	Bristol-Myers Squibb Company	Pyrimidine derivatives as corticotropin releasing factor inhibitors
US7030145B2 (en)	2003-04-18	2006-04-18	Bristol-Myers Squibb Company	Pyridinyl derivatives for the treatment of depression
US7153961B2 (en) *	2003-11-25	2006-12-26	Bristol-Myers Squibb Pharma Co.	Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
US7208596B2 (en)	2003-11-25	2007-04-24	Bristol-Myers Squibb Pharma Company	Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
AR046967A1 (es)	2003-12-22	2006-01-04	Sb Pharmco Inc	Compuesto de pirazol[1,5-a]pirimidina, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
GB0519957D0 (en)	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
JP2009502734A (ja) *	2005-07-29	2009-01-29	アステラス製薬株式会社	Ｌｃｋ阻害剤としての縮合複素環
ES2428543T3 (es)	2006-09-20	2013-11-08	Eli Lilly And Company	Compuestos de tiofenopirazolopirimidina
DE602007009305D1 (de)	2006-09-20	2010-10-28	Lilly Co Eli	Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors
WO2008078091A1 (fr)	2006-12-22	2008-07-03	Astex Therapeutics Limited	Composés hétérocycliques bicycliques servant d'inhibiteurs des fgfr
JP5442449B2 (ja)	2006-12-22	2014-03-12	アステックス、セラピューティックス、リミテッド	新規化合物
EP2167094A2 (fr) *	2007-06-13	2010-03-31	Research Development Foundation	Procédés pour le traitement et la prévention de tauopathies et l'amyloïdose de bêta-amyloïde en modulant la signalisation de récepteur crf
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
GB0720038D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
WO2010118207A1 (fr)	2009-04-09	2010-10-14	Schering Corporation	Dérivés pyrazolo[1, 5-a]pyrimidine en tant qu'inhibiteurs de mtor
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
EP2264035A1 (fr) *	2009-06-04	2010-12-22	Merz Pharma GmbH & Co. KGaA	B antagonistes de la glycine
EP2723746A1 (fr)	2011-06-22	2014-04-30	Vertex Pharmaceuticals Inc.	Composés inhibiteurs de la kinase atr
UA113186C2 (xx)	2011-09-30	2016-12-26		Макроциклічні інгібітори lrrk2 кінази
GB201210686D0 (en)	2012-06-15	2012-08-01	Holsboermaschmeyer Neurochemie Gmbh	V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
US8871754B2 (en)	2012-11-19	2014-10-28	Irm Llc	Compounds and compositions for the treatment of parasitic diseases
LT2925757T (lt)	2012-11-19	2017-12-27	Novartis Ag	Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
CN104903325B (zh)	2012-12-07	2017-10-20	沃泰克斯药物股份有限公司	可用作atr激酶抑制剂的化合物
EP2968237A4 (fr)	2013-03-15	2016-08-31	Univ Johns Hopkins	Procédés et compositions pour améliorer la fonction cognitive
CA2904767C (fr)	2013-03-15	2022-06-21	Agenebio, Inc.	Procedes et compositions pour ameliorer la fonction cognitive
GB201310782D0 (en)	2013-06-17	2013-07-31	Max Planck Innovation Gmbh	Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
SI3077397T1 (sl)	2013-12-06	2020-02-28	Vertex Pharmaceuticals Inc.	2-amino-6-fluoro-N-(5-fluoro-piridin-3-IL)pirazolo(1,5-A)pirimidin-3- karboksamidna spojina, koristna kot inhibitor kinaze ATR, njena priprava, različne trdne oblike in njeni radioaktivno označeni derivati
AU2015271030B2 (en)	2014-06-05	2019-05-16	Vertex Pharmaceuticals Incorporated	Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo [1,5-a] pyrimidin-3-carboxamide compound useful as ATR kinase inhibitor, the preparation of said compound and different solid forms thereof
RU2736219C2 (ru)	2014-06-17	2020-11-12	Вертекс Фармасьютикалз Инкорпорейтед	Способ лечения рака с использованием комбинации ингибиторов снк1 и atr
SG11201701936WA (en)	2014-09-17	2017-04-27	Oncodesign Sa	Macrocyclic lrrk2 kinase inhibitors
MX2017005586A (es)	2014-11-03	2017-06-19	Bayer Pharma AG	Piperidinilpirazolopirimidinonas y utilización de las mismas.
US10925834B2 (en)	2015-05-22	2021-02-23	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
HK1258570A1 (zh)	2015-09-30	2019-11-15	Vertex Pharmaceuticals Inc.	使用dna损伤剂及atr抑制剂的组合治疗癌症的方法
SG11201909710XA (en) *	2017-04-21	2019-11-28	Kyn Therapeutics	Indole ahr inhibitors and uses thereof
AU2018317398A1 (en)	2017-08-14	2019-11-21	Spruce Biosciences, Inc.	Corticotropin releasing factor receptor antagonists
CA3089159A1 (fr) *	2018-02-06	2019-08-15	Jiangsu Hengrui Medicine Co., Ltd.	Derive de pyrazolo[1,5-a][1,3,5]triazine-2-amine, son procede de preparation et son utilisation medicale
AU2019370200B2 (en)	2018-10-30	2024-12-19	Kronos Bio, Inc.	Compounds, compositions, and methods for modulating CDK9 activity
JP2023537598A (ja)	2020-08-12	2023-09-04	スプルースバイオサイエンシーズ，インク．	多嚢胞性卵巣症候群を処置するための方法および組成物
US11708372B2 (en)	2021-11-19	2023-07-25	Spruce Biosciences, Inc.	Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE786611A (fr) *	1971-08-16	1973-01-22	Int Chem & Nuclear Corp	Nouveaux inhibiteurs de xanthine-oxydase et leur procede de preparatio
US3910907A (en) *	1973-07-09	1975-10-07	Icn Pharmaceuticals	Pyrazolo(1,5-a)-1,3,5-triazines
US3995039A (en) *	1975-05-27	1976-11-30	Merck & Co., Inc.	Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (ja) *	1984-08-29	1986-03-24	Shionogi & Co Ltd	縮合複素環誘導体および抗潰瘍剤
US4824834A (en) *	1986-10-31	1989-04-25	Otsuka Pharmaceutical Company, Limited	Pyrazolotriazine compounds
DE3722072A1 (de) *	1987-07-01	1989-01-12	Schering Ag	6,7-dihydro-pyrazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und pflanzenwuchsregulierender wirkung
JP2585462B2 (ja) *	1989-10-25	1997-02-26	株式会社大塚製薬工場	ピラゾロ［１，５―ａ］ピリミジン誘導体
KR927003595A (ko) *	1990-10-09	1992-12-18	오츠카 아키히코	피리미딘 유도체, 이의 제조방법 및 안드로겐 저해제
US5484760A (en) *	1990-12-31	1996-01-16	Monsanto Company	Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides
EP0591528B1 (fr) *	1991-04-22	1998-12-23	Otsuka Pharmaceutical Factory, Inc.	DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE ET AGENT ANTI-INFLAMMATOIRECONTENANT CE DERIVE
US5356897A (en) *	1991-09-09	1994-10-18	Fujisawa Pharmaceutical Co., Ltd.	3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
WO1994013676A1 (fr) *	1992-12-17	1994-06-23	Pfizer Inc.	Pyrrolopyrimidines en tant qu'antagonistes du facteur liberateur de corticotrophine (crf)
PT714898E (pt) *	1994-06-21	2002-04-29	Otsuka Pharma Co Ltd	Derivado de pirazolo¬1,5-a\|pirimidina
WO1996035689A1 (fr) *	1995-05-12	1996-11-14	Neurogen Corporation	Derives nouveaux de deazapurine; une nouvelle classe de ligands specifiques de crf1
CZ244598A3 (cs) *	1996-02-07	1998-10-14	Janssen Pharmaceutica N.V.	Pyrazolopyrimidiny jako antagonisty CRF receptoru

1997
- 1997-07-23 EA EA200301042A patent/EA006626B1/ru not_active IP Right Cessation
- 1997-07-23 AU AU38942/97A patent/AU747708B2/en not_active Expired
- 1997-07-23 AT AT97936222T patent/ATE375344T1/de active
- 1997-07-23 HU HU0102187A patent/HU228962B1/hu unknown
- 1997-07-23 HU HU0500549A patent/HU229024B1/hu unknown
- 1997-07-23 ES ES97936222T patent/ES2294800T3/es not_active Expired - Lifetime
- 1997-07-23 KR KR1019997000568A patent/KR100548853B1/ko not_active Expired - Fee Related
- 1997-07-23 PT PT97936222T patent/PT915880E/pt unknown
- 1997-07-23 DK DK97936222T patent/DK0915880T3/da active
- 1997-07-23 EP EP97936222A patent/EP0915880B1/fr not_active Expired - Lifetime
- 1997-07-23 DE DE69738197T patent/DE69738197T2/de not_active Expired - Lifetime
- 1997-07-23 CZ CZ2005-613A patent/CZ2005613A3/cs unknown
- 1997-07-23 WO PCT/US1997/013072 patent/WO1998003510A1/fr active IP Right Grant
- 1997-07-23 RO RO99-00078A patent/RO121272B1/ro unknown
- 1997-07-23 EP EP07015514A patent/EP1908764A1/fr not_active Withdrawn
- 1997-07-24 AR ARP970103368A patent/AR007994A1/es unknown
- 1997-07-25 TW TW086110640A patent/TW542827B/zh not_active IP Right Cessation
- 1997-07-25 TW TW092105694A patent/TWI238164B/zh not_active IP Right Cessation
1999
- 1999-01-20 LV LVP-99-13A patent/LV12292B/en unknown
2003
- 2003-07-02 HK HK03104703.7A patent/HK1052693A1/zh unknown

Publication	Publication Date	Title
WO1998003510B1 (fr)	1998-04-02
EP1008342A3 (fr)	2004-12-29	Composés pharmaceutiquement actifs et liposomes, et leur application
CA2165819A1 (fr)	1995-11-02	Derives de dc-89
CA2017252A1 (fr)	1990-11-23	Composes inhibiteurs de la protease des retrovirus
CA2171275A1 (fr)	1996-09-08	Derives du stilbene et compositions pharmaceutiques qui en renferment
CA2079692A1 (fr)	1993-04-05	Amino-6-demethyl-6-desoxytetracyclines substituees en 7 et en 9
CA2254833A1 (fr)	1997-12-04	Produit pharmaceutique pour le traitement de troubles neurologiques et neuropsychiatriques
CA2448602A1 (fr)	2002-12-12	Derives de pyrimidine, triazine et pyrazine, recepteurs du glutamate
PL323152A1 (en)	1998-03-16	Derivatives of 1,3-propanodiole as biologically active compounds
CA2195964A1 (fr)	1996-02-08	Pesticides
GB8929076D0 (en)	1990-02-28	Treatment of shock by blocking agents of edrf effect or formation
NO307181B1 (no)	2000-02-21	Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid
CA2181665A1 (fr)	1997-01-22	Melange stabilisateur synergiste
AU3949889A (en)	1990-02-22	The reductive amination of hydroxy-containing compounds
ZA85327B (en)	1985-12-24	Therapeutic compounds
EP1026162A4 (fr)	2001-01-17	Agent anti-rhumatismal
CA2083361A1 (fr)	1993-05-27	Production piscicole
ATE192927T1 (de)	2000-06-15	Neue cephem-derivate
CA2229892A1 (fr)	1997-12-24	Preparations liposomes de derives indolocarbazole
EP0702014A4 (fr)	1996-08-07	Derive dc-89
AU1925392A (en)	1993-01-12	A process for the preparation of n-(2,6-dichlorophenyl)-n-phenyl-n-(chloroacetyl)-amine
CA2193348A1 (fr)	1995-12-28	Derives d'alkyldiamines substituees et leur utilisation en tant qu'antagonistes de la tachykinine
CA2302412A1 (fr)	1999-04-08	Derives d'amino-alkylphenols et composes associes
EP0663816A4 (fr)	1996-04-03	Classe nouvelle de derives de phosphocholine a activite fongicide.
CA2353956A1 (fr)	2000-06-15	Agent therapeutique pour le traitement de la dyserection